Chatbots for dementia still in their infancy, tech researchers find … What to know about new Alzheimer’s drug Aduhelm, from scientist who led the trials … Advocacy group urges OIG to investigate FDA’s approval of new Alzheimer’s drug … First patient receives controversial Biogen Alzheimer’s drug at hospital … LTC care needs will double by 2065 … FDA approves Novartis’ drug for aggressive prostate cancer following positive trial results
